PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsThromboembolism
MeSH D013923 - thromboembolism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D016769:Embolism and thrombosis
0 Companies
0 Drugs
Success rate
D013923: 
Thromboembolism
D002542:Intracranial embolism and thrombosis
$
Success rate
D019320:Paradoxical embolism
0 Companies
0 Drugs
Success rate
D054556:Venous thromboembolism
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaArgatroban Argatroban  2014-12-15   
Taro PharmaceuticalWarfarin Warfarin  1999-07-15   
LEO PharmaTinzaparin Innohep  2000-07-14   
MylanArgatroban Argatroban  2014-06-30   
Heparin Heparin  2017-11-30   
CiplaArgatroban Argatroban 2027-09-26 2011-06-29   
Warfarin Warfarin  2011-05-25   
SandozArgatroban Argatroban  2000-06-30   
Enoxaparin Enoxaparin  2010-07-23   
Heparin Heparin  2011-06-08   
Aspen GlobalHeparin Liquaemin  1982-01-01   
Danaparoid Orgaran  1996-12-24   
OrganonPhenprocoumon Liquamar  1982-01-01   
NovartisHeparin, Lidocaine, Dihydroergotamine Embolex  1984-11-30   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
25%
1/4
Phase 2
48%
13/27
Phase 3
77%
20/26
Approved: 11Overall Success rate: 9%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
LEO Pharma
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use